Category: Legislative

Two_Timely-bg

Commercial Support for CME May Rise in Response to Health Care Reform

New York Times Provides an Analysis of Why Pharmaceutical Companies Should Not Be Barred From Participating in CME

Europe Beating U.S. Hands Down in Oncology

The Debate Over Increased Transparency

Recent Study Shows No Bias in Commercially Supported CME Activities

ACCME Releases 2009 Annual Report Data

AAMC Sees No Need to Cut Off Contacts With Industry

The Cost of Purity for ACCME

AMA Rejects CEJA Industry Collaboration Report for 4th Time